A review on decreased calcium and vitamin b12 absorption with long term proton pump inhibitor therapy

Kilaru Mounika; Pavani Tanniru; Firoz Shaik; Dachinamaoorthi D

doi:10.37022/jpmhs.v3i1.16

Authors

Kilaru Mounika Department of Pharmacy Practice, QIS College of Pharmacy, Pondur Road, Vengamukkapalem, Ongole, Prakasam district, Andhra Pradesh, India – 523272.
Tanniru Pavani Department of Pharmacy Practice, QIS College of Pharmacy, Pondur Road, Vengamukkapalem, Ongole, Prakasam district, Andhra Pradesh, India – 523272.
Dr.Shaik Firoz Department of Pharmacy Practice, QIS College of Pharmacy, Pondur Road, Vengamukkapalem, Ongole, Prakasam district, Andhra Pradesh, India – 523272.
Dr.D.Dachinamaoorthi Department of Pharmacy Practice, QIS College of Pharmacy, Pondur Road, Vengamukkapalem, Ongole, Prakasam district, Andhra Pradesh, India – 523272. `

DOI:

https://doi.org/10.37022/jpmhs.v3i1.16

Keywords:

Proton Pump Inhibitor, Vit B12, Calcium

Abstract

Proton pump inhibitors (PPI) are now one of the most widely used classes of drugs. PPIs have proven to have a very favorable safety profile and it is unusual for a patient to stop these drugs because of side effects. However, increasing numbers of patients are chronically taking PPIs for gastro esophageal reflux disease and a number of other common persistent conditions, therefore the long-term potential adverse effects are receiving increasing attention. Nowadays as PPI are the main drugs used for peptic ulcer disease and GERD ,a part from this they are also preferred in drug induced gastric irritation .In this article these studies are systematically examined, as well as the studies of the effects of chronic PPI usage on VB₁₂ calcium , absorption which leads to neurologic disorders and osteoporosis. In general the studies in each of three areas have led to differing conclusions, but when examined systematically, a number of the studies are showing consistent results that support the conclusion that long-term adverse effects on these processes can have important clinical implications.

Downloads

Download data is not yet available.

References

https://www.cancer.ca/en/cancer. Cited on 21st November 2019.

Dockray GJ. Topical review. Gastrin and gastric epithelial physiology. J. Physiol. (Lond.). 1999 Jul 15;518 ( Pt 2):315-24.

Brooke fidler , proton pump inhibitors, us pharamacist , published date : November 10 , 2017.

Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011;56(4):931–50.https://doi.org/10.1007/s10620-010-1560-3. PMid:21365243.

Jensen RT. Consequences of long-term proton pump blockade: Highlighting insights from studies of patients with gastrinomas. Basic ClinPharmacolToxicol. 2006;98:4–19.

McColl KE. Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol. 2009;104 (Suppl 2):S5–S9.

Termanini B, Gibril F, Sutliff VE, III, et al. Effect of long-term gastric acid suppressive therapy on serum vitamin B12levels in patients with Zollinger-Ellison syndrome. Am J Med. 1998;104:422–430.

Rozgony NR, Fang C, Kuczmarski MF, Bob H. Vitamin B(12) deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: could a cyanocobalamin nasal spray be beneficial? J Nutr Elder. 2010;29:87–99. A recent prospective study demonstrating showing a marked increase of VB12 deficiency in elderly institutionalized subjects using chronic PPIs and the demonstrating the effectiveness of a VB12 nasal spray.

Dharmarajan TS, Kanagala MR, Murakonda P, et al. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008;9:162–167.

Dharmarajan TS, Norkus EP. Does long-term PPI use result in vitamin B12 deficiency in elderly individuals? Nat ClinPractGastroenterolHepatol. 2008;5:604–605.

HasimeQorraj – Bytyqi , RexhepHocha and Elton Bahtiri , Proton Pump inhibitors intake and iron and vitamin b 12 status :A prospective comparitive study with a follow up of 12 months, Published by :NCBI on Mar 12,2018Open Access Maced J Med Sci. 2018 Mar 15; 6(3): 442–446.

Flynn A. The role of dietary calcium in bone health. ProcNutr Soc. 2003;62(4):851-858.

Mizunashi K, Furukawa Y, Katano K, Abe K. Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int.1993;53(1):21-25.

Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947–2953.

Festen HP. Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract. Scand J Gastroenterol. 1991;26:1–7.